Concord Drugs consolidated net profit rises 300.00% in the June 2025 quarter
Sales rise 16.42% to Rs 13.61 crore
Net profit of Concord Drugs rose 300.00% to Rs 0.12 crore in the quarter ended June 2025 as against Rs 0.03 crore during the previous quarter ended June 2024. Sales rose 16.42% to Rs 13.61 crore in the quarter ended June 2025 as against Rs 11.69 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales13.6111.69 16 OPM %7.497.10 -PBDT0.530.38 39 PBT0.160.04 300 NP0.120.03 300Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 09 2025 | 7:37 AM IST